Nanobiotix utilized Euronext for its global offering, with pricing based on the ECB published exchange rate.
1 report, 1 independent
Updated May 26
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Nanobiotix utilized Euronext for its global offering, with pricing based on the ECB published exchange rate.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Nanobiotix
French healthcare company
Nothing else this week.
-
European Central Bank
central bank of the European Union and the eurozone
-
Euronext
pan-European bourse
Related events
- The ECB is connecting blockchain markets, including Ethereum, to payment infrastructure through new services involving Deutsche Bank and Santander.
- Eurostat released consumer price measures for the euro area, while the ECB continues to manage monetary policy.
- GenSight Biologics is listing on Euronext in Paris, subject to Prospectus Regulation.